Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Svetlana V. Elizarova"'
Publikováno v:
Сахарный диабет, Vol 20, Iss 5, Pp 363-373 (2017)
Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and ma
Externí odkaz:
https://doaj.org/article/7064630c00a648cdb4fccd13437a7832
Publikováno v:
Сахарный диабет, Vol 19, Iss 3, Pp 242-250 (2016)
A critical aspect of the treatment of most patients with type 2 diabetes mellitus (T2DM) is the initiation (and subsequent intensification) of insulin therapy when lifestyle interventions and oral anti-hyperglycaemic drugs fail to maintain or improve
Externí odkaz:
https://doaj.org/article/72ce33b77d6449dd98806bc75c8fa576
Publikováno v:
Сахарный диабет, Vol 19, Iss 3, Pp 242-250 (2016)
A critical aspect of the treatment of most patients with type 2 diabetes mellitus (T2DM) is the initiation (and subsequent intensification) of insulin therapy when lifestyle interventions and oral anti-hyperglycaemic drugs fail to maintain or improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe52e6cdeadda4fab77347727cf25745
https://doi.org/10.14341/dm2003429-34
https://doi.org/10.14341/dm2003429-34
Publikováno v:
Journal of Diabetes. 6:100-110
Because of the progressive nature of type 2 diabetes mellitus (T2DM), insulin therapy will eventually become necessary in most patients. Recent evidence suggests that maintaining optimal glycemic control by early insulin therapy can reduce the risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72856d8607cbd9bd46f51647454e7710
https://doi.org/10.1111/1753-0407.12096
https://doi.org/10.1111/1753-0407.12096